These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38040474)

  • 1. ART and cardiovascular-disease risk in people with HIV.
    Malvestutto C
    Lancet HIV; 2023 Dec; 10(12):e760-e761. PubMed ID: 38040474
    [No Abstract]   [Full Text] [Related]  

  • 2. Triad of the Ischemic Cardiovascular Disease in People Living with HIV? Association Between Risk Factors, HIV Infection, and Use of Antiretroviral Therapy.
    Zanetti HR; Mendes EL; Palandri Chagas AC; Gomes Douglas MO; Paranhos Lopes LT; Roever L; Gonçalves A; Santos Resende E
    Curr Atheroscler Rep; 2018 May; 20(6):30. PubMed ID: 29777448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV and cardiovascular risk.
    Moyle G; Randell P
    Clin Med (Lond); 2008 Jun; 8(3):315-8. PubMed ID: 18624046
    [No Abstract]   [Full Text] [Related]  

  • 4. Patterns of cardiovascular risk and disease in HIV-positive adults on anti-retroviral therapy in Mozambique.
    Dobe I; Manafe N; Majid N; Zimba I; Manuel B; Mocumbi A
    Cardiovasc J Afr; 2020; 31(4):190-195. PubMed ID: 32634198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular involvements in HIV-infected patients.
    Alharethi R
    Expert Rev Cardiovasc Ther; 2013 Sep; 11(9):1227-35. PubMed ID: 23972010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis.
    Islam FM; Wu J; Jansson J; Wilson DP
    HIV Med; 2012 Sep; 13(8):453-68. PubMed ID: 22413967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
    Grinspoon S; Carr A
    N Engl J Med; 2005 Jan; 352(1):48-62. PubMed ID: 15635112
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of atherosclerotic cardiovascular disease risks between people living with HIV receiving first-line and second-line antiretroviral therapy in a resource-limited setting.
    Tiarukkitsagul J; Sungkanuparph S
    Int J STD AIDS; 2021 Apr; 32(5):421-426. PubMed ID: 33533302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing drug interactions in HIV-infected adults with comorbid illness.
    Hughes CA; Tseng A; Cooper R
    CMAJ; 2015 Jan; 187(1):36-43. PubMed ID: 25225224
    [No Abstract]   [Full Text] [Related]  

  • 10. Comorbidities and cardiovascular risk factors in an aged cohort of HIV-infected patients on antiretroviral treatment in a Spanish hospital in 2016.
    Fontela C; Castilla J; Juanbeltz R; Martínez-Baz I; Rivero M; O'Leary A; Larrea N; San Miguel R
    Postgrad Med; 2018 Apr; 130(3):317-324. PubMed ID: 29486621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review of Chronic Comorbidities in Adults Living With HIV: State of the Science.
    Webel AR; Schexnayder J; Cioe PA; Zuñiga JA
    J Assoc Nurses AIDS Care; 2021 May-Jun 01; 32(3):322-346. PubMed ID: 33595986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma fibroblast growth factor 23 and osteocalcin serum levels are associated with cardiovascular risk in HIV-1-infected patients receiving antiretroviral treatment.
    Spagnuolo V; Cocorullo D; Galli L; Bigoloni A; Galli A; Rubinacci A; Mignogna G; Carbone A; Lazzarin A; Castagna A
    J Antimicrob Chemother; 2013 Dec; 68(12):2960-3. PubMed ID: 23812682
    [No Abstract]   [Full Text] [Related]  

  • 13. [Metabolic alterations, AIDS and vascular disease].
    Betancor León P
    An Med Interna; 2007 Apr; 24(4):157-9. PubMed ID: 17867897
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of cardio-metabolic risk factors on all-cause mortality among HIV patients on antiretroviral therapy in Malawi: A prospective cohort study.
    Amberbir A; Banda V; Singano V; Matengeni A; Pfaff C; Ismail Z; Allain TJ; Chan AK; Sodhi SK; van Oosterhout JJ
    PLoS One; 2019; 14(1):e0210629. PubMed ID: 30653539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy.
    Fitzpatrick ME; Kunisaki KM; Morris A
    AIDS; 2018 Jan; 32(3):277-292. PubMed ID: 29194119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk factors and lifetime risk estimation in HIV-infected patients under antiretroviral treatment in Spain.
    Estrada V; Bernardino JI; Masiá M; Iribarren JA; Ortega A; Lozano F; Miralles C; Olalla J; Santos J; Elías MJ; Domingo P; Cruz AF
    HIV Clin Trials; 2015; 16(2):57-65. PubMed ID: 25874992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of selected non-communicable disease risk factors among HIV patients on anti-retroviral therapy in Bushbuckridge sub-district, Mpumalanga province.
    Mathebula RL; Maimela E; Ntuli NS
    BMC Public Health; 2020 Feb; 20(1):247. PubMed ID: 32070315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Immune Activation in HIV and Non HIV Subjects and Its Relation to Cardiovascular Disease Risk.
    Vos AG; Dodd CN; Delemarre EM; Nierkens S; Serenata C; Grobbee DE; Klipstein-Grobusch K; Venter WDF
    Front Immunol; 2021; 12():647805. PubMed ID: 34290695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventional cardiovascular procedures among HIV-infected individuals on antiretroviral therapy 1995-2000.
    Braitstein P; Yip B; Heath KV; Levy AR; Montaner JS; Humphries K; Kiely FM; O'Shaughnessy MV; Hogg RS
    AIDS; 2003 Sep; 17(14):2071-5. PubMed ID: 14502010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular health in an aging HIV population.
    Boccara F
    AIDS; 2017 Jun; 31 Suppl 2():S157-S163. PubMed ID: 28471946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.